Pharmaceutical compositions for treatment of Parkinson's disease

Details for Australian Patent Application No. 2009254730 (hide)

Owner Pharma Two B Ltd.

Inventors Sela, Yoram; Lamensdorf, Itschak

Agent Shelston IP

Pub. Number AU-A-2009254730

PCT Pub. Number WO2009/147681

Priority 61/059,326 06.06.08 US

Filing date 7 June 2009

Wipo publication date 10 December 2009

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/4045 (2006.01)

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2009/147681 Priority application(s): WO2009/147681

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009254738-[4-(1-amino-ethyl) -cyclohexyl] - methyl-amine and [6-(1-amino-ethyl) - tetrahydropyran-3-yl] -methyl-amine derivatives as antibacterials

2009254716-Production of potassium magnesium citrate and its applications